Home » Topics » BioWorld Science

BioWorld Science
RSS

Matrix to seek E.U. approval of IntraDose by Q4 2001

Oct. 10, 2001

Copaxone reduces the percentage of permanent "black holes" in MS

Oct. 10, 2001

Exisulind may delay disease progression in prostate cancer patients

Oct. 10, 2001

Active Biotech updates development programs

Oct. 10, 2001

Yamanouchi patents new series of antitumor agents

Oct. 9, 2001

Potential treatments for Alzheimer's disease recently presented by DuPont

Oct. 9, 2001

Antiviral pyrazine derivatives in the Toyama pipeline

Oct. 9, 2001

Marine sponge-derived and synthetic antitumor compounds patented by Pharma Mar

Oct. 9, 2001

GSK developing inhibitors of Lp-PLA2 for atherosclerosis

Oct. 9, 2001

Tularik designs LXR receptor modulators and discusses possible uses thereof

Oct. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads
BioWorld
Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...